Patients living with HIV and tuberculosis (TB) are calling on the Social Health Authority (SHA) to reclassify these diseases to ensure they qualify for coverage under national health insurance schemes. Many affected individuals argue that the current classification leaves them without access to necessary medical services, placing an enormous financial burden on them and their families.
For years, patients with HIV and TB have struggled with healthcare expenses, even as national health programs expand. Many insurance providers, including those under SHA, categorize these illnesses in a way that either excludes them from coverage or limits the benefits that patients can receive.
Currently, some insurance policies classify HIV and TB as chronic or pre-existing conditions, which in many cases excludes them from insurance benefits. As a result, patients are left to bear the costs of life-saving treatments, including antiretroviral therapy (ART) for HIV and long-term medication for drug-resistant TB. The high cost of treatment forces some individuals to abandon care, worsening public health concerns.
Patients and advocacy groups argue that HIV and TB should be treated like any other medical conditions covered by SHA. They insist that failing to provide coverage contradicts public health efforts aimed at controlling the spread of these diseases.
Key reasons for reclassification include:
Financial Relief for Patients – Many individuals affected by HIV and TB struggle to afford treatment, and insurance coverage would significantly reduce the financial strain.
Public Health Benefits – Improved access to healthcare services for HIV and TB patients would lead to better management of these diseases, reducing transmission rates.
Alignment with Global Health Policies – Many countries have universal health coverage policies that include HIV and TB treatment, recognizing them as essential health services.
Reducing Stigma and Discrimination – The exclusion of HIV and TB from full health coverage contributes to stigma, making it harder for patients to seek early diagnosis and treatment.
The Social Health Authority (SHA) plays a crucial role in determining which diseases qualify for coverage under government insurance programs. If SHA agrees to reclassify HIV and TB, it could mean expanded access to free or subsidized healthcare services for thousands of patients.
Some government officials have acknowledged the need for health policy reforms, particularly in light of increasing HIV and TB cases. The World Health Organization (WHO) has emphasized the importance of universal healthcare, urging countries to ensure access to treatment for all individuals, including those with infectious diseases.
The demand to reclassify HIV and TB under SHA’s insurance scheme is gaining momentum as patient advocacy groups and healthcare professionals highlight the need for equitable health coverage. Providing insurance for these diseases would not only ease the financial burden on patients but also contribute to better public health outcomes. The SHA and government authorities must take swift action to ensure that HIV and TB patients receive the healthcare support they deserve.
